Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High frequency of pathogenic germline variants within homologous recombination repair in patients with advanced cancer.
Bertelsen B, Tuxen IV, Yde CW, Gabrielaite M, Torp MH, Kinalis S, Oestrup O, Rohrberg K, Spangaard I, Santoni-Rugiu E, Wadt K, Mau-Sorensen M, Lassen U, Nielsen FC. Bertelsen B, et al. Among authors: lassen u. NPJ Genom Med. 2019 Jun 21;4:13. doi: 10.1038/s41525-019-0087-6. eCollection 2019. NPJ Genom Med. 2019. PMID: 31263571 Free PMC article.
Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patients.
Grunnet M, Christensen IJ, Lassen U, Jensen LH, Lydolph M, Lund IK, Thurison T, Høyer-Hansen G, Mau-Sørensen M. Grunnet M, et al. Among authors: lassen u. Clin Biochem. 2014 May;47(7-8):599-604. doi: 10.1016/j.clinbiochem.2014.01.030. Epub 2014 Feb 12. Clin Biochem. 2014. PMID: 24530340
Personalized oncology: genomic screening in phase 1.
Tuxen IV, Jønson L, Santoni-Rugiu E, Hasselby JP, Nielsen FC, Lassen U. Tuxen IV, et al. Among authors: lassen u. APMIS. 2014 Aug;122(8):723-33. doi: 10.1111/apm.12293. APMIS. 2014. PMID: 25046202 Review.
A phase I monotherapy study of RG7212, a first-in-class monoclonal antibody targeting TWEAK signaling in patients with advanced cancers.
Lassen UN, Meulendijks D, Siu LL, Karanikas V, Mau-Sorensen M, Schellens JH, Jonker DJ, Hansen AR, Simcox ME, Schostack KJ, Bottino D, Zhong H, Roessler M, Vega-Harring SM, Jarutat T, Geho D, Wang K, DeMario M, Goss GD. Lassen UN, et al. Clin Cancer Res. 2015 Jan 15;21(2):258-66. doi: 10.1158/1078-0432.CCR-14-1334. Epub 2014 Nov 11. Clin Cancer Res. 2015. PMID: 25388164 Clinical Trial.
[The genome and cancer treatment].
Nielsen FC, Lassen U. Nielsen FC, et al. Among authors: lassen u. Ugeskr Laeger. 2014 Nov 10;176(46):V07140419. Ugeskr Laeger. 2014. PMID: 25394934 Free article. Review. Danish.
203 results